![Antoun Nabhan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antoun Nabhan
Corporate Officer/Principal chez
Sagamore China Partners I LP
Profil
Antoun Nabhan was the founder of Presidio Pharmaceuticals, Inc., founded in 2006, where the title held was Chief Financial Officer.
Mr. Nabhan is also the founder of Incellico, Inc...
Mr. Nabhan is currently Principal at Sagamore China Partners I LP since 2002.
Former positions include Director at Cellerant Therapeutics, Inc., Principal at Heller Ehrman LLP, Vice President-Corporate Development at Soleno Therapeutics, Inc. in 2014, Principal at Deloitte Consulting LLP, Vice President-Business Development at Tobira Therapeutics, Inc. in 2012, Chief Financial Officer at Establishment Labs SA from 2016 to 2017, Vice President at Pear Therapeutics, Inc. from 2017 to 2020, and Senior Vice President at OCM Distressed Debt Group from 2020 to 2021.
Education includes undergraduate studies at The University of Chicago and graduate studies at Harvard Law School.
Postes actifs de Antoun Nabhan
| Sociétés | Poste | Début |
|---|---|---|
Sagamore China Partners I LP
 Sagamore China Partners I LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01/01/2002 |
Anciens postes connus de Antoun Nabhan
| Sociétés | Poste | Fin |
|---|---|---|
OCM Distressed Debt Group
 OCM Distressed Debt Group Investment ManagersFinance OCM Opportunistic Credit invests in companies located in the United States. The firm provides financing for distressed debt. | Private Equity Investor | 31/12/2021 |
| PEAR THERAPEUTICS, INC. | Private Equity Investor | 01/11/2020 |
Establishment Labs SA
 Establishment Labs SA Medical SpecialtiesHealth Technology Designs, develops and manufactures breast health and wellness equipment | Directeur Financier/CFO | 01/05/2017 |
| SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | 17/12/2014 |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Corporate Officer/Principal | - |
Formation de Antoun Nabhan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Heller Ehrman LLP
 Heller Ehrman LLP Miscellaneous Commercial ServicesCommercial Services Provides legal Services | Commercial Services |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
Deloitte Consulting LLP
 Deloitte Consulting LLP Miscellaneous Commercial ServicesCommercial Services Provides financial consulting services | Commercial Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OCM Distressed Debt Group
OCM Distressed Debt Group Investment ManagersFinance OCM Opportunistic Credit invests in companies located in the United States. The firm provides financing for distressed debt. | Finance |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Incellico, Inc. | |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops small-molecule antiviral therapeutics | Health Technology |
Sagamore China Partners I LP
Sagamore China Partners I LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Harvard Law School
 Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Establishment Labs SA
Establishment Labs SA Medical SpecialtiesHealth Technology Designs, develops and manufactures breast health and wellness equipment | Health Technology |
Pear Therapeutics, Inc.
 Pear Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a commercial stage healthcare company that develops software based medicines | Technology Services |
